DA.PVG.1AV1-(D4Rat63-D4Rat203) |
maximum body weight loss to initial body weight ratio |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120 days-200 days |
10 |
14.6 |
% |
1.8 |
5.69 |
body weighing method |
0.0 |
0 |
|
|
69810 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
percentage of study population developing experimental arthritis during a period of time |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
10 |
100.0 |
% |
|
|
in vivo visual assessment |
0.0 |
0 |
|
|
69723 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
percentage of study population developing experimental arthritis during a period of time |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
10 |
90.0 |
% |
|
|
in vivo visual assessment |
0.0 |
0 |
|
|
69725 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
serum orosomucoid 1 level |
squalene (200 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
orosomucoid 1 amount |
both |
120 days-180 days |
10 |
480.0 |
mg/l |
|
|
radial immunodiffusion assay |
0.0 |
0 |
radial immunodiffusion assay |
blood alpha-1-acid glycoprotein amount |
69768 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
10 |
15.5 |
d |
0.8 |
2.53 |
in vivo visual assessment |
0.0 |
0 |
|
|
69793 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
percentage of study population developing experimental arthritis during a period of time |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 37 |
5.0 |
% |
|
|
in vivo visual assessment |
0.0 |
0 |
|
|
70201 |
1301 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
percentage of study population developing experimental arthritis during a period of time |
squalene (200 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
10 |
100.0 |
% |
|
|
in vivo visual assessment |
0.0 |
0 |
|
|
69721 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
serum orosomucoid 1 level |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
orosomucoid 1 amount |
both |
120 days-180 days |
10 |
750.0 |
mg/l |
|
|
radial immunodiffusion assay |
0.0 |
0 |
radial immunodiffusion assay |
blood alpha-1-acid glycoprotein amount |
69772 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
serum orosomucoid 1 level |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
orosomucoid 1 amount |
both |
120 days-180 days |
10 |
660.0 |
mg/l |
|
|
radial immunodiffusion assay |
0.0 |
0 |
radial immunodiffusion assay |
blood alpha-1-acid glycoprotein amount |
69770 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
post-insult time to onset of experimental arthritis |
squalene (200 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
10 |
16.9 |
d |
0.6 |
1.9 |
in vivo visual assessment |
0.0 |
0 |
|
|
69789 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
maximum body weight loss to initial body weight ratio |
squalene (200 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120 days-200 days |
10 |
6.6 |
% |
2.5 |
7.91 |
body weighing method |
0.0 |
0 |
|
|
69808 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
maximum body weight loss to initial body weight ratio |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120 days-200 days |
10 |
12.6 |
% |
2.7 |
8.54 |
body weighing method |
0.0 |
0 |
|
|
69812 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
post-insult time to onset of experimental arthritis |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
10 |
16.4 |
d |
0.8 |
2.53 |
in vivo visual assessment |
0.0 |
0 |
|
|
69791 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 37 |
14.0 |
d |
0.0 |
0.0 |
in vivo visual assessment |
0.0 |
0 |
|
|
70202 |
1301 |